Differential device performances for hepatic arterial chemotherapy: A technical report on totally implantable pumps and ports for both continuous and bolus infusion

European Surgical Research

Volumn 30, Issue 1, 1998, Pages 26-33

  Civalleri, D ^a   DeCian, F ^a   Pellicci, R ^b   Balletto, Nadia ^c   Simoni, G ^a   Cosimelli, M ^d   Mondini, G ^a   Bignami, Paola ^e   Cagol, P P ^f  

^a UNIVERSITY OF GENOA   (Italy)

^b SANTA CORONA HOSPITAL   (Italy)

^c VILLA SCASSI HOSPITAL   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY OF UDINE   (Italy)

Author keywords

Colorectal neoplasms; Implantable devices; Infusion pumps; Infusions, intra arterial; Liver neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; FLOXURIDINE;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; COLORECTAL TUMOR; CONTINUOUS INFUSION; DISEASE COURSE; DRUG TOXICITY; FEMALE; HUMAN; INFUSION PUMP; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MINIPUMP; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; FLOXURIDINE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0031975727     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008554     Document Type: Article

References (33)

1. Niederhuber JE, Ensrninger W, Gyves JW, Liepman M, Doan K, Cozzi RN: Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982,92:706-712.
2. Balch CM, Urist MM, McGregor ML: Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. Am J Surg 1983; 145:285-290.
3. Damascelli B, Marchianò A, Spreafico C, Lutman R, Salvetti M, Bonalumi MG, Mauri M, Garbagnati F, DelNero A, Comeri G, Conti G, Coppoli S, Benetti G, Tralongo P, Belussi D: Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable pump. Cancer 1990;66:237-241.
4. Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ: Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 1986;57:465-470.
5. Lafon PC, Reed K, Rosenthal D: Acute cholecystitis associated with hepatic arterial infusion of floxuridine. Am J Surg 1985;150:687-689.
6. Doei R, Bignami P, Quagliuolo V, Civalleri D, Simoni GA, Cosimelli M, Craus W, Gennari L: Continuous hepatic arterial infusion with 5-fluorodeoxyuridine for treatment of colorectal metastases. Reg Cancer Treat 1990;3:13-18.
7. Cherqui D, Garden OJ, Bismuth H: Duodenal erosion complicating an implanted hepatic arterial access device. Br J Surg 1988;75:556.
8. Civalleri D, Scopinaro G, Balletto N, Claudiani F, DeCian F, Camerini G, DePaoli M, Bonalumi U: Changes of tumour vascularity after hepatic arterial embolization with degradable starch microspheres. Br J Surg 1989;76:699-703.
9. Civalleri D, Scopinaro G, Simoni GA, Claudiani F, Repetto M, DeCian F, Bonalumi U: Starch micro sphere-induced arterial flow redistribution after occlusion of replaced hepatic arteries in patients with metastases. Cancer 1986;58:2151-2155.
10. Civalleri D, Pector JC, Håkansson L, Arnaud JP, Duez N, Buyse M: Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres. Br J Surg 1994;81:1338-1341.
11. Eckhauser FE, Knol JA, Strodel WE, Shellito JL: Complicated access for regional infusion chemotherapy. Arch Surg 1984;119:1195-1197.
12. Cosimelli M, Mannella E, Anzà M, Civalleri D, Balletto N, DiTora P, Durante F, Porcellana M, Cavaliere P, Anfossi A, Morandi GB, Cagol PP, DaPian PP, Cortesi E, Garofalo A, Ruggeri E, Falchero V, Giannarelli D: Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: An alternative to FUdR-based regimen. J Surg Oncol 1991; suppl 2:63-68.
13. Mobile MT, Vidili MG, Sertoli MR, Venturini M, Simoni G, Civalleri D, Bertoglio S, Percivale PL, Torelli P, Spagliardi E, Rosso R: Intrahepatic epidoxorubicin in metastatic and primary liver tumours: A phase II study. Anticancer Res 1991;11:861-864.
14. Nanninga AG, deVries EG, Willemse PH, Oosterhuis BE, Sleijfer DT, Hoekstra HJ, Mulder NH: Continuous infusion of chemotherapy on an outpatient basis via a totally implantable venous access port. Eur J Cancer 1991;27:147-149.
15. Safi F, Schumacher K, Roscher R, Bittner R, Beger MG: Regional chemotherapy of liver metastases of colorectal carcinoma: Monitoring with arterial computed tomography. Cancer Invest 1990;8:123-134.
16. Savolaine ER, Zeiss J, Schlembach PJ, Skeel RT, McCann K, Merrick MW: Role of scintigraphy in establishing optimal perfusion in hepatic arterial infusion pump chemotherapy. Am J Clin Oncol 1989;12:68-84.
17. Sidibe S, Rougier P, Lumbroso, Edeline V, Lasser P, Elias D, Ducreux M, Parmentier C: Contrôles de perfusion par angioscintigraphie lors des chimiothérapies intra-artérielles hépatiques. Presse Méd 1989; 18:2045-2049.
18. Ziessman HA, Thrall JH, Yang PJ, Walker SC, Cozzi EA, Niederhuber JK, Gyves JW, Ensminger ND, Tuscan MC: Hepatic arterial perfusion scintigraphy with Tc-99m-MAA. Use of a totally implanted drug delivery system. Radiology 1984;152: 167-172.
19. Cohen AM, Higgins J, Waltman AC, Athanasoulis C, McKusick K: Effect of ligation of variant hepatic arterial structures on the completeness of regional chemotherapy infusion. Am J Surg 1987;153:378-380.
20. Rayner AA, Kerlan RK, Stagg RJ, Price DC, Hohn DC: Total hepatic arterial perfusion after occlusion of variant lobar vessels. Implications for hepatic arterial chemotherapy. Surgery 1986;99:706-715.
21. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J; Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-1260.
22. Elias D, Lasser P, Rougier P: A simplified surgical technical procedure for intra-arterial chemotherapy in secondary liver cancer. Experience in 50 patients. Eur J Surg Oncol 1987;13:441-448.
23. Doria MI Jr, Doria LK, Faintuch J, Levin B: Gastric mucosal injury after hepatic arterial infusion chemotherapy with floxuridine. A clinical and pathologic study. Cancer 1994; 73:2042-2047.
24. Johnson LP, Rivkin SE: The implanted pump in metastatic liver cancer of the liver. Risk versus benefit. Am J Surg 1985;149:595-598.
25. Seeger J, Woodcock TM, Blumenreich MS, Richardson JD: Hepatic perfusion with FUdR utilizing an implantable system in patients with liver primary cancer or metastatic cancer confined to the liver. Cancer Invest 1989;7:1-6.
26. Campbell KA, Burns RC, Sitzmann JV, Lipsett PA, Grochow LB, Niederhuber JE: Regional chemotherapy devices: Effect of experience and anatomy on complications. J Clin Oncol 1993;11:822-826.
27. Curley SA, Chase JL, Roh MS, Hohn DC: Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993;114:928-935.
28. Kernstine KH, Kryjeski SR, Hall LJ, Larson RE, Saylor HL, Fortuny IE: Gastroduodenal artery-duodenal fistula: A complication of continuous floxuridine (FUDR) infusion into the gastroduodenal artery. J Surg Oncol 1990;45:59-62.
29. Seeger J, Woodcock TM, Richardson JD: Complications of implantable chemotherapy pump. A case of pump inversion. Cancer Res 1985; 56:2428-2429.
30. Sterchi JM: Hepatic artery infusion for metastatic neoplastic disease. Surg Gynecol Obstet 1985;160:477-489.
31. Warren HW, Anderson JH, O'Gorman P, Kerr DJ, Cooke TG, McArdle CS: Ambulatory infusion pumps for intrahepatic arterial chemotherapy. Reg Cancer Treat 1993;2:77-78.
32. Lanning RM, Hrushesky WJM: Estimated costs of continuous infusion chemotherapy. J Infus Ther 1992;2: 89-93.
33. Patt YZ, Mavligit GM: Arterial chemotherapy in the management of colorectal cancer An overview. Semin Oncol 1991;18:478-490.